Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
BioVectra is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Canada
Founded:2018
Employees:2,237
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Asia-Pacific
Manufacturing Facilities
1 site worldwide
BioVectra Inc
29 McCarville St, Charlottetown, PE C, 1E 2A7
Site Capabilities
1 capabilityAPI MANUFACTURE
Regulatory Approvals
Drug Approval ZO89JG
FDA · #APR-UPIRKS71 · 2020-12-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-MGI79T4M
Issued: 2020-12-05
Expires: 2025-01-07
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-NIMEPT0H
Issued: 2020-09-08
Expires: 2025-07-11
Loading CDMO intelligence...
Key facts about BioVectra
- BioVectra is headquartered in Canada.
- BioVectra was founded in 2018.
- BioVectra has 2,237 employees.
- BioVectra has one manufacturing site listed on CDMO Hub, in Charlottetown, Canada.
- BioVectra's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like BioVectra
Directory pages this company appears in, each with the full list of matching manufacturers.